Real time Cellectis (CLLS) stock price quote, stock graph, news & analysis. by MarketWatch. View the latest market news and prices, and trading information. What Makes Cellectis S.A. (CLLS) a New Strong Buy Stock. Cellectis S.A. Cellectis S.A. American Depositary Shares (CLLS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 5 Wall Street analysts have issued 1 year target prices for Cellectis' shares. Their forecasts range from $11.00 to $73.00. On average, they anticipate Cellectis' Stock Price Forecast. The 14 analysts offering 12-month price forecasts for Cellectis SA have a median target of 32.50, with a high estimate of 73.00 and a low Stock analysis for Cellectis SA (CLLS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View Cellectis S.A. CLLS investment & stock information. Get the latest Cellectis S.A. CLLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and
CLLS - Cellectis S.A. ADR Stock Price - Barchart.com
ETFs with exposure to Cellectis SA : November 15, 2017 Capital Cube Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. CLLS | Cellectis S.A. ADR Stock Price & News - WSJ View the latest Cellectis S.A. ADR (CLLS) stock price, news, historical charts, analyst ratings and financial information from WSJ. CLLS: Cellectis SA - Stock Price, Quote and News - CNBC
Cellectis S.A. American Depositary Shares (CLLS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Find the latest Cellectis S.A. (CLLS) stock quote, history, news and other vital information to help you with your stock trading and investing.
CLLS: Cellectis SA - Stock Price, Quote and News - CNBC
Get breaking news and analysis on Cellectis S.A. (CLLS) stock, price quote and chart, trading and investing tools. Cellectis SA Sponsored ADR - TheStreet - Stock Market Trade-Ideas: Cellectis (CLLS) Is Today's Weak On High Relative Volume Stock. By TheStreet Wire. Jul 8, 2016 10:33 AM EDT. VIDEO. CEOs Should Set Tone for Corporate Culture. By Rhonda Schaffler. Cellectis S.A. ADR Stock Price (CLLS) | Barron's View today's stock price, news and analysis for Cellectis S.A. ADR (CLLS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. CLLS: Cellectis S.A. - Greek Montage - Zacks.com CLLS: Cellectis S.A. Greek Montage stock information. Get the latest Greek Montage stock quote information from Zacks Investment Research
View the real-time ORC price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying
Apr 01, 2020 · Following Series of US and European Patent Grants, Cellectis Strengthens its Intellectual Property on CRISPR-Edited T-cell Therapies Regulatory News: Cellectis (CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells, today announced that a new patent from the US Patent and Trademark Office had been … Cellectis Stock Quote. CLLS - Stock Price, News, Charts ... Cellectis stock quote and CLLS charts. Latest stock price today and the US's most active stock market forums. CLLS Stock Price, Forecast & News (Cellectis) | MarketBeat News stories about CLLS stock have been trending neutral on Wednesday, according to InfoTrie. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. Cellectis SA Ads (CLLS) Stock Quote | Price Chart | Volume ... View a financial market summary for CLLS including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to CLLS (Cellectis SA Ads) stock.